¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"binary acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • mycolic acid
    ¹ÌÄÝ»ê
  • malonic acid
    ¸»·Ð»ê
  • myristic acid
    ¹Ì¸®½ºÆ¾»ê
  • mandelic acid
    ¸¸µ¨»ê
  • methacrylic acid
    ¸ÞŸũ¸±»ê
  • methylhippuric acid
    ¸ÞÆ¿È÷Ǫ¸£»ê
  • N-acetylneuraminic acid
    N-¾Æ¼¼Æ¿´º¶ó¹Î»ê
  • neuraminic acid
    ´º¶ó¹Î»ê
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
  • nitric acid
    Áú»ê
  • nitrobenzoic acid
    ´ÏÆ®·Îº¥Á¨»ê
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    ¾ÆÁú»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • phenolsulfuric acid
    Æä³îȲ»ê
  • phenylpyruvic acid
    Æä´ÒÇÇ·çºê»ê
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇÇ·çºê»ê
  • picramic acid
    ÇÇÅ©¶÷»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê
  • pyruvic acid
    ÇÇ·çºê»ê
  • retinoic acid
    ·¹Æ¼³ë»ê, ·¹Æ¼³ëÀλê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • saccharic acid
    »çÄ«¸°»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • saturated acid
    Æ÷È­Áö¹æ»ê
  • sialic fatty acid
    ½Ã¾Ë»ê
  • spermanucleic acid
    Á¤ÀÚÇÙ»ê
  • succinic acid
    ¼÷½Å»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • arsenous acid
    ¾Æºñ»ê(ä¬Ý÷ß«).
  • free acid
    À¯¸®»ê(ë´ìÆß«).
  • free fatty acid
    À¯¸®Áö¹æ»ê.
  • free fatty acid.
    À¯¸®Áö¹æ»ê
  • fuming sulfuric acid
    ¹ß¿¬È²»ê(¡­üÜß«).
  • gastric acid
    À§»ê(ß«)
  • gastric acid secretion
    À§(êÖ)(¾×(äû))»êºÐºñ(ß«ÝÂÝô).
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • general acid
    ÀϹݻê(ìéÚõß«).
  • glacial acetic acid
    ºùÃÊ»ê.
  • glucosidase, alpha-glucosidase(acid maltase)
    -±Û·çÄڽõ¥À̽º, -glucosidase
  • glucuronic acid
    ±Û·çÄí·Ð»ê.
  • glucuronic acid pathway
    ±Û·çÄí·Ð»ê°æ·Î.
  • glutamic acid
    ±Û·çŽ»ê.
  • glutamic acid dehydrogenase
    ±Û·çŽ»êÅ»¼ö¼ÒÈ¿¼Ò, ±Û·çŽ»êµ¥È÷µå·Î°Ô<³ª>Á¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • carbonic acid
    ź»ê.
  • carbonic acid
    ź»ê
  • carbonic acid
    ź»ê
  • carbonic acid
    ź»ê(÷©ß«)
  • carbonic acid assimilation
    ź¼Òµ¿È­ (¡­ÔÒûù).
  • cell wall teichoic acid
    ¼¼Æ÷º® ŸÀÌÄÚ»ê
  • cellular retinoid acid-bindin gprotein
    ¼¼Æ÷³» ·¹Æ¼³ëÀ̵å»ê°áÇմܹé(¡­Ì¿ùêÓ±ÛÜ)
  • cerebric acid
    ³ú»ê(Òàß«).
  • cerebronic acid
    ¼¼·¹ºê·Ð»ê.
  • chamber acid
    ¿¬½ÇȲ»ê(æçãøüÜß«).
  • chenodeoxycholic acid
    Äɳ뵥¿Á½ÃÄݸ°»ê
  • chitonic acid
    Űſ»ê(¡­ß«)
  • cholic acid
    ´ãÁó»ê
  • cholic acid
    ÄÝ»ê(ß«)
  • chondroitin sulfuric acid =chs
    Äܵå·ÎÀÌÆ¾È²»ê(¡­üÜß«).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • eleostearic acid
    Àϸ®¿À½ºÅ׾Ƹ£»ê(ß«)
  • erythorbic acid
    ¿¡¸®Å丣ºê»ê(ß«)
  • essential amino acid
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«)
  • essential amino acid index
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«) Áö¼ö(ò¦â¦)
  • essential fatty acid
    Çʼö Áö¹æ»ê (ù±âÎò·Û¸ß«)
  • ethylenediaminetetraacetic acid
    ¿¡Æ¿·»ÀÌ(ì£)¾Æ¹Î»ç(ÞÌ)¾Æ¼¼Æ®»ê(ß«)
  • ethylenedinitrolotetraacetic acid
    ¿¡Æ¿·»ÀÌ(ì£)³ªÀÌÆ®·Î»ç(ÞÌ)¾Æ¼¼Æ®»ê(ß«)
  • even-numbered fatty acid
    ¦¼ö Áö¹æ»ê(ß«)
  • fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • fatty acid activating enzyme
    Áö¹æ»ê Ȱ¼ºÈ­ È¿¼Ò (ò·Û¸ß«üÀàõûùý£áÈ)
  • fatty acid activation
    Áö¹æ»ê Ȱ¼ºÈ­ (ò·Û¸ß«üÀàõûù)
  • fatty acid CoA ligase
    Áö¹æ»ê(ò·Û¸ß«) CoA ¶óÀ̰ÔÀ̽º
  • fatty acid oxidation
    Áö¹æ»ê »êÈ­ (ò·Û¸ß«ß«ûù)
  • fatty acid synthetase system
    Áö¹æ»ê ÇÕ¼º È¿¼Ò(ò·Û¸ß«ùêà÷ý£áÈ)½Ã½ºÅÛ
  • fatty acid thiokinase
    Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
LA lactic acid; large amount; laser angioplasty; late abortion; late antigen; latex agglutination; left...
LAD lactic acid dehydrogenase; left anterior descending [artery]; left axis deviation; leukocyte adhesio...
MA malignant arrhythmia; management and administration; mandelic acid; masseter; Master of Arts; matern...
PAP pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa...
PAS para aminosalicylate; Parent Attitude Scale; patient administration system; patient appointments and...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
RA 13-cis-Retinoic Acid
EET 14,15-Epoxyeicosatrienoic acid
ETYA 14-eicosatetraynoic acid
AIB 14C-alpha-amino-isobutyric acid
15 S-HETE 15 S-hydroxyeicosatetraenoic acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metaphosphoric acid
    ¸ÞŸÀλê
    ÀλêÀÇ Çϳª. Çü»óÀ¸·Î º¸¾Æ À¯¸®»ó ÀÎ»ê ¶Ç´Â ºù»ó ÀλêÀ̶ó°íµµ ÇÑ´Ù. È­ÇÐ½Ä HPO. ¹Ì»ý¹°, °ïÃæ·ù ¶Ç´Â ¾î¶² Á¾·ùÀÇ µ¿¹°ÀÇ Á¶Á÷ µî¿¡ Á¸ÀçÇÑ´Ù. ¹«»ö Åõ¸íÇÑ À¯¸®»ó °íü ¶Ç´Â ºÎµå·¯¿î ºñ´Ü½Ç ¸ð¾çÀÇ ±«»ó ¹°Áú·Î, ºÐÀÚ·® 79.98, ºñÁß 2.2ÀÌ´Ù. Á¶ÇؼºÀ̸ç, ½ÀÇÑ °ø±â ¼Ó¿¡ ¹æÄ¡ÇÏ¸é ¿À¸£Åä Àλê HPO°¡ µÈ´Ù. ¹°, ¿¡Åº¿Ã¿¡ Àß ³ì´Â´Ù. °¡¿­ÇÏ¸é ¿ëÀ¶ÇÏ¿© Á¡¼ºµµ°¡ Áõ°¡ÇÏ°í ´õ¿í °¡¿­ÇÏ¸é ½ÂÈ­ÇÑ´Ù. ¼ö¿ë¾× ¼Ó¿¡¼­´Â ÁßÇÕü¸¦ Àß ¸¸µé°í, °£´ÜÇÑ °Íµµ »ïÇÕü³ª »çÇÕü°¡ µÇÁö¸¸, Àå½Ã°£ ¹æÄ¡ÇÏ¸é ¿À¸£ÅäÀλêÀ¸·Î º¯ÇÑ´Ù. ¸ÞŸÀÎ»ê ¿ë¾×¿¡ Áú»ê Àº ¿ë¾×À» °¡ÇÏ¸é ¹é»ö ħÀüÀÌ »ý±ä´Ù. ¸ÞŸÀλêÀº ¿À¸£ÅäÀÎ»ê ¶Ç´Â ÇÇ·ÎÀλê HPOÀ» 300 ¡É ÀÌ»óÀ¸·Î °¡¿­ÇÏ¸é »ý±ä´Ù. 2HPO 2j HPO+HO HPO 2j 2HPO+HO ¶Ç ¿À»êÈ­ÀÎÀ» 0 ¡É ÀÌÇÏ·Î ¼öÈ­ÇØµµ ¾ò´Â´Ù. Ä¡°ú¿ë ½Ã¸àÆ® , È­Çкм®¿ë ½Ã¾à, º¸ÀÏ·¯ ûÁ¤Á¦, ÀμâÁ¦ÆÇ, °¡Á×ÀÇ ¹«µÎÁú µî¿¡ ¾²À̸ç, Ä®·ý¿°Àº À¯Á¦Ç°ÀÇ Á¡¼ºµµ Áõ°¡Á¦, ¼¼Á¦, ÇÜ, ¼Ò½ÃÁöÀÇ Ã·°¡Á¦·Î »ç¿ëµÈ´Ù. ¶ÇÇÑ, ¸ÞŸÀλêÀº »ý¹°ÇлóÀ¸·Îµµ ¸Å¿ì Èï¹Ì·Î¿î ¼ºÁúÀ» °¡Áö°í Àִµ¥, È¿¸ð¿¡¼­´Â ÇÙ»êÀÇ ÇÕ¼º¿¡ ÇÊ¿äÇÑ Àΰú ¿¡³ÊÁö¸¦ ¸ÞŸÀλêÀÌ °ø±ÞÇÏ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • methacrylic acid
    ¸ÞŸ ¾ÆÅ©¸¯ »ê
  • morrhuate sodium : °£À¯ÀÇ Áö¹æ»ê ³ªÆ®·ý¿°. °æÈ­Á¦·Î¼­ ƯÈ÷ Á¤¸Æ·ù ¹× Ä¡ÁúÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç Á¤¸Æ·ù ³»·Î ¿ë¾×À» ÁÖ»çÇÑ´Ù.

    morrhuic acid

    ¸ð·çÀλê
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • mycolic acid
    ¹ÌÄÝ»ê.
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p-¾Æ¹Ì³ë ¾È½ÄÇâ»ê
  • nalidixic acid
    ³¯¸®µñ½º»ê
    C
  • naphthalenesulfonic acid
    ³ªÇÁÅ»·» ¼úÆù»ê
    ³ªÇÁÅ»·»À» ¼úÆùÈ­½ÃŰ¸é »ý±â´Â È­ÇÕ¹°. 1-³ªÇÁÅ»·» ¼úÆù»ê°ú 2-³ªÇÁÅ»·» ¼úÆù»êÀÇ µÎ À̼ºÁúü°¡ ÀÖ´Ù. ÀüÀÚ´Â 60 ¡É ÀÌÇÏÀÇ ¹ÝÀÀ ¿Âµµ¿¡¼­ ¾òÀ» ¼ö ÀÖ°í, ÈÄÀÚ´Â 165 ¡É¿¡¼­ ¾òÀ» ¼ö ÀÖ´Ù. ¾ËÄ®¸® À¶ÇØÇÏ¸é ³ªÇÁÅçÀ» ¾ò´Â´Ù. ³ªÇÁÅ»·»À» ¿ø·á·Î ÇÏ´Â ¿°·á´Â ´ëºÎºÐ ³ªÇÁÅ»·» ¼úÆù»êÀ» °ÅÃÄ ÇÕ¼ºµÇ¹Ç·Î ¿°·á °ø¾÷¿¡ ¸Å¿ì Áß¿äÇÏ´Ù. ¸ð³ë ¼úÆù»êÀ» ´Ù½Ã ¼úÆùÈ­Çϸé Á¶°Ç¿¡ µû¶ó ¿©·¯ ¼úÆù»êÀÌ »ý±ä´Ù. ¶Ç ³ªÇÁÅç ¼úÆù»êÀÇ ¾Æ¹Ì³ë À¯µµÃ¼, ³ªÇÁÅç ¼úÆù»ê µîÀÌ ¿°·á Áß°£Ã¼·Î¼­ ¸¹ÀÌ »ý¼ºµÈ´Ù.
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nissl's acid
    ´Ï½½»ê
    »ê¼º¾× ¶Ç´Â ¾Ï¸ð´Ï¾Æ¿¡ ³ì´Â´Ù.
  • nitrobenzoic acid
    ´ÏÆ®·Î ¾È½ÄÇâ »ê
    NO2C6H4COOH. ´ÏÆ®·Î Åç·ç¿ÃÀÌ »êÈ­µÇ¾î »ý±â´Â È­ÇÕ¹°.
  • nitroferrocyanic acid
    ´ÏÆ®·Î Æä·Î½Ã¾È»ê
    H2[Fe
  • octanoic acid
    ¿ÁÅ×Àλê
  • oleic acid
    ¿Ã·¹»ê
    µ¿½Ä¹°¿¡ ³Î¸® Á¸ÀçÇÏ´Â Áö¹æ»ê. È­ÇÐ½Ä C8H4O, ³ì´ÂÁ¡ 12 ¡É, ²ú´ÂÁ¡ 360 ¡ÉÀÌ´Ù. ÀÌÁß °áÇÕÀ» 1°³ °¡Áö´Â ºÒÆ÷È­ Áö¹æ»êÀÌ´Ù. ¹°¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª, ¿¡Åº¿Ã, ¿¡Å׸£, Ŭ·Î·ÎÆ÷¸§ µî¿¡´Â ³ì´Â´Ù. ¹é±ÝÈæ, ´ÏÄÌ µîÀ» Ã˸ŷΠÇÏ¿© ¼ö¼Ò·Î ȯ¿ø½ÃŰ¸é Æ÷È­ÀÎ ½ºÅ׾Ƹ£»êÀÌ µÈ´Ù. ¼ø¼öÇÑ °ÍÀº ¹«»ö, ¹«ÃëÀÎ À¯»ó ¾×üÀ̳ª, °ø±â ¼Ó¿¡ ¹æÄ¡ÇØ µÎ¸é »êÈ­µÇ¾î Ȳ»ö ¶Ç´Â °¥»öÀ¸·Î Âø»öµÇ°í ½â´Â ³¿»õ°¡ ³­´Ù. µ¿¹°¿¡¼­´Â ±Û¸®¼¼¸°°ú ¿¡½ºÅ׸£¸¦ Çü¼ºÇÏ¿© ÇÇÇÏ Áö¹æÀ̳ª °£¿¡ ÀúÀåµÈ´Ù. °ø¾÷ÀûÀ¸·Î ¿ëµµ°¡ ³ÐÀ¸¸ç, ºñ´©ÀÇ ¿ø·á³ª õÀÇ ¹æ¼öÁ¦·Î¼­ ÀÌ¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
amino acid dehydrogenases Enzymes catalyzing the oxidative deamination of amino acids to the corresponding oxo (keto) acids; two relatively non-specific varieties exist, l and d, for which l-amino acids and d-amino acids are the respective substrates; the products include NH3 and a reduced hydrogen acceptor (NADH in the l case); amino acid dehydrogenases of greater specificity exist, (e.g., glycine dehydrogenase).
Compare: amino acid oxidases.
(05 Mar 2000)
amino acid isomerases <enzyme> Enzymes that catalyze either the racemization or epimerization of chiral centres within amino acids or derivatives.
Registry number: EC 5.1.1.-
(12 Dec 1998)
amino acid naphthylamidases <enzyme> Registry number: EC 3.4.11.
(12 Dec 1998)
amino acid neurotransmitters Amino acids released by neurons as intercellular messengers. Among the amino acid neurotransmitters are glutamate (glutamic acid) and gaba which are, respectively, the most common excitatory and inhibitory neurotransmitters in the central nervous system.
(12 Dec 1998)
amino acid oxidases Flavoenzymes oxidizing, with O2 and H20, either l-or d-amino acids specifically, to the corresponding 2-keto acids, NH3 and H2O2.
Compare: amino acid dehydrogenases, yellow enzyme.
(05 Mar 2000)
amino acid oxidoreductases <enzyme> A class of enzymes that catalyze oxidation-reduction reactions of amino acids.
Registry number: EC 1.4.
(12 Dec 1998)
amino acid permease <enzyme> A widely distributed group of large Integral membrane proteins, required for the entry of amino acids into cells.
(18 Nov 1997)
amino acid reagent A reagent used in the identification and quantification of amino acids.
(05 Mar 2000)
amino acid receptor <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor.
(18 Nov 1997)
amino acid sequence The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation.
(12 Dec 1998)
amino acid substitution The naturally occurring or experimentally induced replacement of one or more amino acids in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
(12 Dec 1998)
amino acid transmitter <biochemistry> Amino acids released as neurotransmitter substances from nerve terminals and acting on postsynaptic receptors for example _ aminobutyric acid (GABA) and glycine that are fast inhibitory transmitters in the mammalian central nervous system.
Glutamate and aspartate mediate fast excitatory transmission. Strychnine (for glycine) and bicuculline for GABA) are blocking agents for amino acid action.
(18 Nov 1997)
aminocaproic acid <chemistry> A group of compounds that are derivatives of aminohexanoic acids.
<haematology> An antifibrinolytic agent, used to prevent bleeding in haemophilia, and after heart and prostate surgery when plasminogen or urokinase may be activated.
(05 Mar 2000)
aminocarboxylic acid <biochemistry> A class of organic molecules that containing an amino group and can combine in linear arrays to form proteins in living organisms.
There are twenty common amino acids: alanine, arginine, aspargine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
They are key components in all living things from which proteins are synthesised by formation of peptide bonds during ribosomal translation of messenger RNA.
All the amino acids have the L configuration, except glycine which is not optically active. Other amino acids occurring in proteins, such as hydroxyproline in collagen, are formed by post translational enzymatic modification of amino acid residues in polypeptide chains.
There are also several important amino acids, such as the neurotransmitter y aminobutyric acid, that have no relation to proteins.
Amino acids can now be produced by biotechnology in bulk using fermentation and biotransformation.
Acronym: AA
(13 Nov 1997)
aminocitric acid HOOCCH(NH3+)C(COOH)(OH)CH2CO; OH;found in acid hydrolysates of ribonucleoprotein in human spleen.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á